Jul 24, 2026
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.65 to $6.53.
The split itself did not change the total investment value.
Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) operates in the Biotechnology industry.
Apimeds Pharmaceuticals US, Inc. company overviewApimeds Pharmaceuticals US, Inc.'s most recent stock split was on July 24, 2026. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) has split its stock 2 times: a 1-for-10 reverse split on March 26, 2026 and a 1-for-10 reverse split on July 24, 2026.
Apimeds Pharmaceuticals US, Inc. has split its stock 2 times. This history records 2 reverse splits between March 26, 2026 and July 24, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Apimeds Pharmaceuticals US, Inc.'s 1-for-10 reverse split on July 24, 2026, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Apimeds Pharmaceuticals US, Inc. has not announced a new split in our records. Its most recent split was on July 24, 2026, less than a year ago. Companies announce splits in advance, and any new AMEX:APUS split will appear on this page.